期刊文献+

冠心病病人PCI前后Hs-CRP变化及其相关因素 被引量:2

CHANGES AND RELATIVE FACTORS OF HIGH SENSITIVITY C-REACTIVE PROTEIN IN PATIENTS WITH CORONARY HEART DISEASE BEFORE AND AFTER PERCUTANEOUS CORONARY INTERVENTION
下载PDF
导出
摘要 目的探讨能够引起经皮冠状动脉介入治疗(PCI)术后血清超敏C-反应蛋白(Hs-CRP)水平升高的独立危险因素。方法行选择性冠状动脉支架置入术的急性冠状动脉综合征(ACS)病人195例,于术前、术后24h测定血清Hs-CRP水平,计算术后与术前Hs-CRP水平之差(ΔCRP)。根据ΔCRP≤3mg/L和>3mg/L分为两组,比较两组临床特征,并行ΔCRP的多因素Logistic回归分析。结果两组间高密度脂蛋白、支架个数、支架长度、支架重叠、靶病变类型B2/C、多支病变差异有统计学意义(t=2.059~7.747,χ2=12.333~65.090,P<0.05、0.01)。ACC/AHA病变分型B2/C、支架长度、支架数目、支架重叠和多支病变是引起ΔCRP升高的独立预测因子。结论 ACC/AHA病变分型B2/C、支架长度、支架数目、支架重叠和多支病变是引起PCI术后Hs-CRP水平升高的独立危险因素。 Objective To explore the independent risk factors that raise high-sensitivity C-reactive protein(Hs-CRP) level in patients after percutaneous coronary intervention(PCI). Methods A selective coronary stenting was performed in 195 patients with acute coronary syndrome(ACS).The serum level of Hs-CRP was detected before and 24 hours after PCI,the difference of Hs-CRP between before and after PCI was calculated.The patients were divided into two groups based on CRP≤3 mg/L and 3 mg/L,the clinical features were compared and multivariate logistic regression analysis done. Results The differences between the two groups were significant in terms of the level of HDL,ACC/AHA type B2/C lesion,length and number of stent,the incidence of stent overlapping and multivessel stenting(t=2.059-7.747;χ2=12.333-65.090;P〈0.05,0.01),all the above items were independent predictors of high Hs-CRP. Conclusion The independent risk factors responsible for increasing post-PCI Hs-CRP are ACC/AHA type B2/C lesion,length and number of stent,stent overlapping and multivessel stenting.
出处 《齐鲁医学杂志》 2012年第2期152-154,共3页 Medical Journal of Qilu
关键词 冠状动脉疾病 C反应蛋白质 血管成形术 经腔 经皮冠状动脉 危险因素 coronary disease C-reactive protein angioplasty transluminal percutaneous coronary risk factors
  • 相关文献

参考文献9

  • 1MAGADLE R,HERTZ I,MERLON H,et al.The relation-ship between preprocedural C-reactive protein levels and earlyand late complications in patients with acute myocardial infarc-tion undergoing interventional coronary angioplasty[J].ClinCardiol,2004,27:163-168. 被引量:1
  • 2朱京伟,刘成玉.冠心病病人血清sCD14和hs-CRP变化及其临床意义[J].青岛大学医学院学报,2008,44(2):156-157. 被引量:6
  • 3YEH E T.High-sensitivity C-reactive protein as a risk assess-ment tool for cardiovascular disease[J].Clin Cardiol,2005,28:408-412. 被引量:1
  • 4GACH O,LEGRAND V,BIESSAUX Y,et al.Long-termprognostic significance of high-sensitivity C-reactive protein be-fore and after coronary angioplasty in patients with stable angi-na pectoris[J].Am J CardioL,2007,99:31-35. 被引量:1
  • 5LENDERINK T,BOERSMA E,HEESCHEN C,et al.Ele-vated troponin T and Creactive protein predict impaired out-come for 4years in patients with refractory unstabLe angina,and troponin T predicts benefit of treatment with abciximab incombination with PTCA[J].Eur Heart J,2003,24:77-85. 被引量:1
  • 6ZAIRIS M N,AMBROSE J A,MANOUSAKIS S J,et al.The impact of plasma Levels of C-reactive protein,lipoprotein(a)and homocysteine on the long-term prognosis after suc-cessful coronary stenting:The GlobaL Evaluation of New E-vents and Restenosis After Stent Implantation Study[J].AmColl Cardiol,2002,40(8):1375-1382. 被引量:1
  • 7MOSES J W,LEON M B,POPMA J J,et al.Sirolimus-elu-ting stents versus standard stents in patients with stenosis in anative coronary artery[J].N Engl J Med,2003,349(14):1315-1323. 被引量:1
  • 8文美,毛华,陈晶晶,刘庭筑,须五平,李莉佳.冠心病患者介入治疗后不同时期白细胞介素-8、C反应蛋白及血浆P选择素的变化[J].临床心血管病杂志,2006,22(1):25-27. 被引量:7
  • 9KASTRATI A,MEHILLI J,DIRSCHINGER J,et al.Res-tenosis after coronary placement of various stent types[J].Am J Cardiol,2001,87(1):34-39. 被引量:1

二级参考文献15

共引文献11

同被引文献14

  • 1孟晓雪,张博,潘明,张钲.早发冠心病介入治疗前后高敏C-反应蛋白动态变化的临床意义[J].中华临床医师杂志(电子版),2011,5(21):6478-6480. 被引量:5
  • 2周健,吕虹,康熙雄.中国汉族人群不同性别、年龄、体重指数之间细胞色素氧化酶CYP2C19基因多态性的检测[J].中国临床药理学与治疗学,2007,12(2):208-213. 被引量:84
  • 3BASSUK SS, RIFAI N, RIDKER PM.High-sensitivity C-reaetive protein: clinical import-ance[J].Curr Probl Cardiol, 2004, 3(1): 439-493. 被引量:1
  • 4郑露,邵建国.CYP2C19的基因多态性与临床[J].第二军医大学学报,2007,28(11):1262-1265. 被引量:19
  • 5TOLLESNN T R, NEWTV L K, HAN INGTON R A, et al. Frequency of slenl thrombosis atiex' wute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trial)[J]. Am J Cardiol, 2003,92:330 -333. 被引量:1
  • 6TOLLESON T R, NEWBYLK, HARRINGTON R A, et al. Frequency of stent thrombosis after acute coronary syndromes [J]. Am J Cardiol, 2003,92(3) ,302-333. 被引量:1
  • 7KAZUI M, NISHIYAY, ISHIUKAT, et aI. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivatlon of clopidogrel to itspharmacologieally actvemetabolite [J]. Drug Metab Dispos, 2010,38:92- 99. 被引量:1
  • 8DUPONT A G, GABRIEL D A, COHEN M G. Antiplatelet therapies and the role of antlplatelet resistance in acute coro- nary syndrome[J]. Thromb Res, 2009,124 ( 1 ) : 6-13. 被引量:1
  • 9HULOT J S, BURA A, VILLARD E, et al. Cytochrome P450 2C19 loss-of-function polymorphim is a majr determinant of clopidogrel responsiveness in healthy subjects [J]. Blood, 2006,108 (7) : 2244-2247. 被引量:1
  • 10S1MON T, VERSTUYFT C, MARY-KRAUSE M, et al. Ge- netic determinants of response to clopidogrel and cardiovascu- lar events[J]. N Engl J Med, 2009,360:363-376. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部